Skip to NavigationSkip to content

PureTech appoints Julie Krop as Chief Medical Officer

Published on: 25/08/21

Clinical-stage biotherapeutics company PureTech has appointed Julie Krop as Chief Medical Officer.

Krop will oversee all clinical development, Regulatory, CMC, and medical affairs for the company’s advancing Wholly Owned Pipeline.

Daphne Zohar, Founder and Chief Executive Officer of PureTech, said: "Julie is a biopharmaceutical industry veteran with a wide breadth of expertise across multiple therapeutic areas and orphan indications.

We believe her expertise in mid- to late-stage clinical development, in addition to her extensive experience as a board-certified physician and leader in regulatory affairs, will be important assets as we advance our lead programme.”

Mission Statement is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches